Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Use of 3-dimensional computed tomography for planning a complex sleeve bronchoplasty with total parenchyma-sparing resection of a carcinoid tumour in the right main bronchus.

Betser L, De Wolf J, Glorion M, Chapelier A.

Interact Cardiovasc Thorac Surg. 2019 May 22. pii: ivz124. doi: 10.1093/icvts/ivz124. [Epub ahead of print]

PMID:
31115440
2.

Cancer events in Belgian nursing home residents: An EORTC prospective cohort study.

Wildiers H, Mauer M, Elseviers M, De Wolf J, Hatse S, Hamaker M, Buntinx F, De Lepeleire J, Uytterschaut G, Falandry C, Tryfonidis K, Janssen-Heijnen M.

J Geriatr Oncol. 2019 Mar 18. pii: S1879-4068(19)30001-3. doi: 10.1016/j.jgo.2019.03.005. [Epub ahead of print]

3.

Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma.

Tranchant R, Quetel L, Montagne F, De Wolf J, Meiller C, De Koning L, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D.

Lung Cancer. 2018 Dec;126:15-24. doi: 10.1016/j.lungcan.2018.10.015. Epub 2018 Oct 16.

PMID:
30527180
4.

Anterior Mediastinal Tracheostomy: Past, Present, and Future.

Wurtz A, De Wolf J.

Thorac Surg Clin. 2018 Aug;28(3):277-284. doi: 10.1016/j.thorsurg.2018.03.002. Review.

PMID:
30054064
5.

Letter to the Editor.

De Wolf J, Brian E, Wurtz A.

J Pediatr Surg. 2018 Apr;53(4):857-858. doi: 10.1016/j.jpedsurg.2017.12.004. Epub 2017 Dec 29. No abstract available.

PMID:
29366505
6.

Medication use in a cohort of newly admitted nursing home residents (Ageing@NH) in relation to evolving physical and mental health.

Ivanova I, Wauters M, Stichele RV, Christiaens T, De Wolf J, Dilles T, Elseviers M.

Arch Gerontol Geriatr. 2018 Mar - Apr;75:202-208. doi: 10.1016/j.archger.2018.01.005. Epub 2018 Jan 17.

PMID:
29353187
7.

Exhaustive preoperative staging increases survival in resected adrenal oligometastatic non-small-cell lung cancer: a multicentre study.

De Wolf J, Bellier J, Lepimpec-Barthes F, Tronc F, Peillon C, Bernard A, Le Rochais JP, Tiffet O, Sage E, Chapelier A, Porte H.

Eur J Cardiothorac Surg. 2017 Oct 1;52(4):698-703. doi: 10.1093/ejcts/ezx193.

PMID:
29156014
8.

Repeated Resections of Hepatic and Pulmonary Metastases from Colorectal Cancer Provide Long-Term Survival.

Bellier J, De Wolf J, Hebbar M, Amrani ME, Desauw C, Leteurtre E, Pruvot FR, Porte H, Truant S.

World J Surg. 2018 Apr;42(4):1171-1179. doi: 10.1007/s00268-017-4265-3.

PMID:
28948336
9.

Real-Time Computed Tomography Highlights Pulmonary Parenchymal Evolution During Ex Vivo Lung Reconditioning.

Sage E, De Wolf J, Puyo P, Bonnette P, Glorion M, Salley N, Roux A, Liu N, Chapelier A.

Ann Thorac Surg. 2017 Jun;103(6):e535-e537. doi: 10.1016/j.athoracsur.2016.12.029.

PMID:
28528061
10.

Successful immunosuppressant-free heterotopic transplantation of tracheal allografts in the pig.

De Wolf J, Brieu M, Zawadzki C, Ung A, Kipnis E, Jashari R, Hubert T, Fayoux P, Mariette C, Copin MC, Wurtz A.

Eur J Cardiothorac Surg. 2017 Aug 1;52(2):248-255. doi: 10.1093/ejcts/ezx116.

PMID:
28472471
11.

Association Between Genetic Variation in FOXO3 and Reductions in Inflammation and Disease Activity in Inflammatory Polyarthritis.

Viatte S, Lee JC, Fu B, Espéli M, Lunt M, De Wolf JN, Wheeler L, Reynolds JA, Castelino M, Symmons DP, Lyons PA, Barton A, Smith KG.

Arthritis Rheumatol. 2016 Nov;68(11):2629-2636. doi: 10.1002/art.39760.

12.

Correction of Pectus Excavatum by Custom-Made Silicone Implants: Contribution of Computer-Aided Design Reconstruction. A 20-Year Experience and 401 Cases.

Wurtz A, De Wolf J, Brian E, Benhamed L, Conti M, Neviere R.

Plast Reconstr Surg. 2017 Jan;139(1):324e-325e. doi: 10.1097/PRS.0000000000002885. No abstract available.

PMID:
27643415
13.

Logistic ex Vivo Lung Perfusion for Hyperimmunized Patients.

De Wolf J, Puyo P, Bonnette P, Roux A, Le Guen M, Parquin F, Chapelier A, Sage E.

Ann Thorac Surg. 2016 Sep;102(3):e205-e206. doi: 10.1016/j.athoracsur.2016.01.081.

PMID:
27549543
14.

[What place for lung volume reduction surgery for emphysema?]

De Wolf J, Bonnette P, Sage É, Hamid A.

Rev Mal Respir. 2017 Feb;34(2):147-154. doi: 10.1016/j.rmr.2016.05.004. Epub 2016 Jul 18. Review. French.

PMID:
27444695
15.

eComment. Coronary artery revascularization and pectus excavatum repair: When and how?

Hysi I, De Wolf J, Neviere R, Wurtz A.

Interact Cardiovasc Thorac Surg. 2016 Aug;23(2):334. doi: 10.1093/icvts/ivw219. No abstract available.

PMID:
27431823
16.

eComment. A versatile flap based on the internal thoracic pedicle: the thymopericardial fat flap.

Wurtz AJ, De Wolf J, Rousse N, Loobuyck V.

Interact Cardiovasc Thorac Surg. 2016 Jul;23(1):178. doi: 10.1093/icvts/ivw169. No abstract available.

17.

eComment. Simultaneous repair of pectus deformities and cardiac surgery under cardiopulmonary bypass.

Wurtz AJ, Rousse N, De Wolf J, Loobuyck V.

Interact Cardiovasc Thorac Surg. 2016 May;22(5):675-6. doi: 10.1093/icvts/ivw081. No abstract available.

18.

Conservatively treated extended tracheal necrosis complicating pharyngolaryngectomy.

De Wolf J, Fournier C, Surmei E, Bellier J, Porte HL.

Ann Thorac Surg. 2015;99(5):1810-1. doi: 10.1016/j.athoracsur.2014.06.119.

PMID:
25952216
19.

Optical Absorption Microspectroscopy (μ-OAS) Based on Schwarzschild-Type Cassegrain Optics.

Chassé M, Lelong G, van Nijnatten P, Schoofs I, de Wolf J, Galoisy L, Calas G.

Appl Spectrosc. 2015 Apr;69(4):457-63. doi: 10.1366/14-07628. Epub 2015 Mar 1.

PMID:
25741926
20.

Aging impairs long-term hematopoietic regeneration after autologous stem cell transplantation.

Woolthuis CM, Mariani N, Verkaik-Schakel RN, Brouwers-Vos AZ, Schuringa JJ, Vellenga E, de Wolf JT, Huls G.

Biol Blood Marrow Transplant. 2014 Jun;20(6):865-71. doi: 10.1016/j.bbmt.2014.03.001. Epub 2014 Mar 7.

21.

Loss of quiescence and impaired function of CD34(+)/CD38(low) cells one year following autologous stem cell transplantation.

Woolthuis CM, Brouwers-Vos AZ, Huls G, de Wolf JT, Schuringa JJ, Vellenga E.

Haematologica. 2013 Dec;98(12):1964-71. doi: 10.3324/haematol.2013.086744. Epub 2013 Sep 13.

22.

Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program.

Abouyahya I, Alhan C, Westers TM, te Boekhorst PA, Kappers-Klunne MC, Coenen JL, Heyning FH, Huls GA, de Wolf JT, Imholz AL, Koene HR, Veth G, de Kruijf EJ, Muus P, Planken EV, Segeren CM, Vasmel WL, van der Velden AM, Velders GA, Koedam J, Ossenkoppele GJ, van de Loosdrecht AA.

Leuk Lymphoma. 2013 Apr;54(4):874-7. doi: 10.3109/10428194.2012.728702. Epub 2012 Sep 28. No abstract available.

PMID:
22971215
23.

Clinical significance of Koebner phenomenon in vitiligo.

van Geel N, Speeckaert R, De Wolf J, Bracke S, Chevolet I, Brochez L, Lambert J.

Br J Dermatol. 2012 Nov;167(5):1017-24. doi: 10.1111/j.1365-2133.2012.11158.x. Epub 2012 Sep 5.

PMID:
22950415
24.

In vivo hemostatic efficacy of polyurethane foam compared to collagen and gelatin.

Broekema FI, van Oeveren W, Selten MH, Meijer RJ, de Wolf JT, Bos RR.

Clin Oral Investig. 2013 May;17(4):1273-8. doi: 10.1007/s00784-012-0809-y. Epub 2012 Aug 2.

PMID:
22855267
25.

Development and validation of a capillary electrophoresis method for the determination of escitalopram and sensitive quantification of its enantiomeric impurity in formulations.

Deng X, De Wolf J, Vervoort R, Pamperin D, Adams E, Schepdael AV.

Electrophoresis. 2012 Jun;33(11):1648-51. doi: 10.1002/elps.201100580.

PMID:
22736368
26.

In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial.

van Geel N, Speeckaert R, Mollet I, De Schepper S, De Wolf J, Tjin EP, Luiten RM, Lambert J, Brochez L.

Pigment Cell Melanoma Res. 2012 Jan;25(1):57-65. doi: 10.1111/j.1755-148X.2011.00922.x. Epub 2011 Nov 2.

PMID:
21982055
27.

F-18 FLT PET: a noninvasive diagnostic tool for visualization of the bone marrow compartment in patients with aplastic anemia: a pilot study.

Agool A, Slart RH, Kluin PM, de Wolf JT, Dierckx RA, Vellenga E.

Clin Nucl Med. 2011 Apr;36(4):286-9. doi: 10.1097/RLU.0b013e31820aa1a1.

PMID:
21368602
28.

An assessment of clinical interchangeability of TEG and RoTEM thromboelastographic variables in cardiac surgical patients.

Venema LF, Post WJ, Hendriks HG, Huet RC, de Wolf JT, de Vries AJ.

Anesth Analg. 2010 Aug;111(2):339-44. doi: 10.1213/ANE.0b013e3181e368bc. Epub 2010 Jun 7.

PMID:
20529981
29.

Extramedullary haematopoiesis imaging with 18F-FLT PET.

Agool A, Dierckx RA, de Wolf JT, Vellenga E, Slart RH.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1620. doi: 10.1007/s00259-010-1486-1. Epub 2010 May 29. No abstract available.

30.

Transfused stored platelets have the same haemostatic function as circulating native platelets.

Roeloffzen WW, Kluin-Nelemans HC, Veeger NJ, Bosman L, de Wolf JT.

Vox Sang. 2010 Aug 1;99(2):123-30. doi: 10.1111/j.1423-0410.2010.01337.x. Epub 2010 Apr 23.

PMID:
20456723
31.

Thrombocytopenia affects plasmatic coagulation as measured by thrombelastography.

Roeloffzen WW, Kluin-Nelemans HC, Mulder AB, de Wolf JT.

Blood Coagul Fibrinolysis. 2010 Jul;21(5):389-97. doi: 10.1097/MBC.0b013e328335d0e4.

PMID:
20410815
32.

In normal controls, both age and gender affect coagulability as measured by thrombelastography.

Roeloffzen WW, Kluin-Nelemans HC, Mulder AB, Veeger NJ, Bosman L, de Wolf JT.

Anesth Analg. 2010 Apr 1;110(4):987-94. doi: 10.1213/ANE.0b013e3181d31e91.

PMID:
20357143
33.

Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.

Huls G, Mulder AB, Rosati S, van de Loosdrecht AA, Vellenga E, de Wolf JT.

Blood. 2010 Jul 15;116(2):180-2. doi: 10.1182/blood-2010-01-263087. Epub 2010 Mar 1.

34.

Effects of red blood cells on hemostasis.

Roeloffzen WW, Kluin-Nelemans HC, Bosman L, de Wolf JT.

Transfusion. 2010 Jul;50(7):1536-44. doi: 10.1111/j.1537-2995.2010.02586.x. Epub 2010 Feb 11.

PMID:
20158685
35.

Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531).

Pullarkat VA, Gernsheimer TB, Wasser JS, Newland A, Guthrie TH Jr, de Wolf JT, Stewart R, Berger D.

Am J Hematol. 2009 Aug;84(8):538-40. doi: 10.1002/ajh.21463. No abstract available.

36.

Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria.

Houwerzijl EJ, Pol HW, Blom NR, van der Want JJ, de Wolf JT, Vellenga E.

Leukemia. 2009 May;23(5):886-91. doi: 10.1038/leu.2008.389. Epub 2009 Jan 15.

PMID:
19148135
37.

Platelet production rate predicts the response to prednisone therapy in patients with idiopathic thrombocytopenic purpura.

Houwerzijl EJ, Louwes H, Sluiter WJ, Smit JW, Vellenga E, de Wolf JT.

Ann Hematol. 2008 Dec;87(12):975-83. doi: 10.1007/s00277-008-0537-1. Epub 2008 Aug 9.

PMID:
18690441
38.

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL.

Lancet. 2008 Feb 2;371(9610):395-403. doi: 10.1016/S0140-6736(08)60203-2.

PMID:
18242413
39.

A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia.

Daenen S, van Imhoff GW, de Wolf JT, Vellenga E, van den Berg-de Ruiter E, Kluin-Nelemans HC.

Br J Haematol. 2007 Jul;138(2):275-7. No abstract available.

PMID:
17593034
40.

The cyclin-dependent kinase inhibitor Orysa;KRP1 plays an important role in seed development of rice.

Barrôco RM, Peres A, Droual AM, De Veylder L, Nguyen le SL, De Wolf J, Mironov V, Peerbolte R, Beemster GT, Inzé D, Broekaert WF, Frankard V.

Plant Physiol. 2006 Nov;142(3):1053-64. Epub 2006 Sep 29.

41.

Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death.

Houwerzijl EJ, Blom NR, van der Want JJ, Vellenga E, de Wolf JT.

Leukemia. 2006 Nov;20(11):1937-42. Epub 2006 Sep 7. Review.

PMID:
16990774
42.

Thromboelastographic evaluation of recombinant factor VIIa in a child with Glanzmann's thrombasthenia.

Ismael F, van der Meer J, de Wolf JT, Kuizenga K, Aarts LP, Hendriks HG.

Anesth Analg. 2006 Sep;103(3):791-2. No abstract available.

PMID:
16931713
43.

Naked (C5Me5)2M cations (M = Sc, Ti, and V) and their fluoroarene complexes.

Bouwkamp MW, Budzelaar PH, Gercama J, Del Hierro Morales I, de Wolf J, Meetsma A, Troyanov SI, Teuben JH, Hessen B.

J Am Chem Soc. 2005 Oct 19;127(41):14310-9.

PMID:
16218625
44.

Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands.

Postma MJ, van Hulst M, De Wolf JT, Botteman M, Staginnus U.

Transfus Med. 2005 Oct;15(5):379-87.

PMID:
16202052
45.

Splenectomy for the treatment of thrombotic thrombocytopenic purpura.

Kappers-Klunne MC, Wijermans P, Fijnheer R, Croockewit AJ, van der Holt B, de Wolf JT, Löwenberg B, Brand A.

Br J Haematol. 2005 Sep;130(5):768-76. Review.

PMID:
16115135
46.
47.

Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation.

Hendriks HG, van der Meer J, de Wolf JT, Peeters PM, Porte RJ, de Jong K, Lip H, Post WJ, Slooff MJ.

Transpl Int. 2005 Jan;17(11):673-9. Epub 2004 Dec 10.

PMID:
15717214
48.

Adjusted transfusion triggers improve transfusion practice in orthopaedic surgery.

Eindhoven GB, Diercks RL, Richardson FJ, van Raaij JJ, Hagenaars JA, van Horn JR, de Wolf JT.

Transfus Med. 2005 Feb;15(1):13-8.

PMID:
15713124
49.

Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study.

Hovenga S, Daenen SM, de Wolf JT, van Imhoff GW, Kluin-Nelemans HC, Sluiter WJ, Vellenga E.

Ann Hematol. 2005 May;84(5):311-6. Epub 2004 Dec 17.

PMID:
15605244
50.

Increased peripheral platelet destruction and caspase-3-independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients.

Houwerzijl EJ, Blom NR, van der Want JJ, Louwes H, Esselink MT, Smit JW, Vellenga E, de Wolf JT.

Blood. 2005 May 1;105(9):3472-9. Epub 2004 Nov 12.

Supplemental Content

Loading ...
Support Center